Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patients.

Baldoncini R, Desideri G, Bellini C, Valenti M, De Mattia G, Santucci A, Ferri C.

Kidney Int. 1999 Oct;56(4):1499-504.

2.

Angiotensin II increases the release of endothelin-1 from human cultured endothelial cells but does not regulate its circulating levels.

Ferri C, Desideri G, Baldoncini R, Bellini C, Valenti M, Santucci A, De Mattia G.

Clin Sci (Lond). 1999 Mar;96(3):261-70.

PMID:
10029562
3.

Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy.

De Mattia G, Cassone-Faldetta M, Bellini C, Bravi MC, Laurenti O, Baldoncini R, Santucci A, Ferri C.

Am J Hypertens. 1998 Aug;11(8 Pt 1):983-8.

PMID:
9715792
4.

Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.

Ferri C, Desideri G, Baldoncini R, Bellini C, De Angelis C, Mazzocchi C, Santucci A.

Diabetes. 1998 Apr;47(4):660-7.

PMID:
9568701
5.

Plasma endothelin-1 levels during transient acute myocardial ischaemia in men: effects of coronary revascularization.

Ferri C, De Marzio P, Desideri G, Baldoncini R, Bellini C, Morelli S, Santucci A.

Eur J Clin Invest. 1997 Jun;27(6):526-32.

PMID:
9229234
6.

Circulating endothelin-1 levels in obese patients with the metabolic syndrome.

Ferri C, Bellini C, Desideri G, Baldoncini R, Properzi G, Santucci A, De Mattia G.

Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:38-40.

PMID:
9288542
7.

Elevated albumin excretion in nonmodulating essential hypertensive patients.

Baldoncini R, Bellini C, Desideri G, De Angelis C, Ferri C, Santucci A.

Nephron. 1997;76(3):264-9.

PMID:
9226225
8.

Elevated plasma endothelin-1 levels as an additional risk factor in non-obese essential hypertensive patients with metabolic abnormalities.

Ferri C, Bellini C, Desideri G, Baldoncini R, De Siati L, Santucci A.

Diabetologia. 1997 Jan;40(1):100-2.

PMID:
9028725
9.

Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients.

Baldoncini R, Ferri C, Bellini C, Desideri G, De Angelis C, Santucci A.

Clin Invest Med. 1996 Feb;19(1):13-9.

PMID:
8868311
10.

Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension.

Morelli S, Ferri C, Di Francesco L, Baldoncini R, Carlesimo M, Bottoni U, Properzi G, Santucci A.

Ann Rheum Dis. 1995 Sep;54(9):730-4.

11.

Plasma endothelin-1 levels in obese hypertensive and normotensive men.

Ferri C, Bellini C, Desideri G, Di Francesco L, Baldoncini R, Santucci A, De Mattia G.

Diabetes. 1995 Apr;44(4):431-6.

PMID:
7698512
12.

Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.

Ferri C, Carlomagno A, Coassin S, Baldoncini R, Cassone Faldetta MR, Laurenti O, Properzi G, Santucci A, De Mattia G.

Diabetes Care. 1995 Feb;18(2):226-33.

PMID:
7729302
13.

Hormonal and renal responses to atrial natriuretic peptide infusion in low-renin hypertension.

Ferri C, Baldoncini R, Bellini C, Di Francesco L, Luparini RL, Cacciafesta, Santucci A.

Am J Nephrol. 1995;15(3):222-9.

PMID:
7618647
14.

Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patients.

Ferri C, Bellini C, Coassin S, Baldoncini R, Luparini RL, Perrone A, Santucci A.

Circulation. 1994 Dec;90(6):2859-69.

PMID:
7994831
15.

Effects of atrial natriuretic factor infusion on plasma prorenin levels in hypertensive males.

Baldoncini R, Ferri C, De Siati L, Coassin S, Bellini C, Cacciafesta M, Santucci A, Balsano F.

Clin Exp Hypertens. 1994 May;16(3):283-302.

PMID:
8038755
16.

Urinary kallikrein excretion and plasma atrial natriuretic peptide in human salt-sensitive hypertension.

Ferri C, Bellini C, Carlomagno A, Baldoncini R, De Siati L, Perrone A, Santucci A, Balsano F.

J Hypertens Suppl. 1993 Dec;11(5):S212-3. No abstract available.

PMID:
8158350
17.

Octreotide, a somatostatin analog, reduces insulin secretion and increases renal Na+ excretion in lean essential hypertensive patients.

Ferri C, De Mattia G, Bellini C, Laurenti O, Bravi C, Baldoncini R, Bonavita MS, Santucci A, Balsano F.

Am J Hypertens. 1993 Apr;6(4):276-81.

PMID:
8507446
18.

[Sodium-modulating hormones and the pressor response to sodium chloride in essential arterial hypertension].

Ferri C, Di Francesco L, Baldoncini R, Bellini C, Desideri G, Carlomagno A, De Siati L, Santucci A, Balsano F.

Ann Ital Med Int. 1993 Apr-Jun;8(2):89-94. Italian.

PMID:
8353025
19.

Renal sodium excretory function during acute oxygen administration.

De Siati L, Baldoncini R, Coassin S, De Angelis C, Ferri C, Santucci A, Perrone A, Balsano F.

Respiration. 1993;60(6):338-42.

PMID:
8290798
20.

Effects of short-time insulin suppression on renal sodium excretion in type II diabetic hypertensives.

Porzano AM, Baldoncini R, De Siati L, Coassin S, Desideri G, Ferri C, Laurenti O, De Mattia G, Santucci A, Balsano F.

Diabetes Res. 1993;22(1):3-10.

PMID:
8200182

Supplemental Content

Loading ...
Support Center